XML 66 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Restructuring and Other Charges
6 Months Ended
Jun. 30, 2014
Restructuring and Related Activities [Abstract]  
RESTRUCTURING AND OTHER CHARGES
RESTRUCTURING AND OTHER CHARGES
Restructuring Charges
The following table summarizes the impact of the Company’s restructuring charges on the condensed consolidated statements of operations:
 
 
Three Months Ended
 
Six Months Ended
 
 
June 30,
 
June 30,
 
 
2014
 
2013
 
2014
 
2013
Cost of sales – services
 
$
139

 
$
4,235

 
$
839

 
$
6,859

Cost of sales – products
 
54

 
78

 
68

 
217

Selling and administrative expense
 
487

 
1,629

 
4,952

 
7,516

Research, development and engineering expense
 
16

 
1,613

 
(26
)
 
2,466

Total
 
$
696

 
$
7,555

 
$
5,833

 
$
17,058



The following table summarizes the Company’s restructuring charges by reporting segment:
 
 
Three Months Ended
 
Six Months Ended
 
 
June 30,
 
June 30,
 
 
2014
 
2013
 
2014
 
2013
Severance
 
 
 
 
 
 
 
 
North America (NA)
 
$
559

 
$
3,883

 
$
2,697

 
$
13,411

Asia Pacific (AP)
 
52

 
604

 
307

 
604

Europe, Middle East and Africa (EMEA)
 
(10
)
 
355

 
587

 
257

Latin America (LA)
 

 

 
1,242

 

Brazil
 
32

 
2,634

 
937

 
2,646

Total Severance
 
633

 
7,476

 
5,770

 
16,918

 
 
 
 
 
 
 
 
 
Other
 
 
 
 
 
 
 
 
EMEA
 
63

 
79

 
63

 
140

Total Other
 
63

 
79

 
63

 
140

Total
 
$
696

 
$
7,555

 
$
5,833

 
$
17,058



During the first quarter of 2013, the Company announced a multi-year realignment plan. Certain aspects of this plan were previously disclosed under the Company's global realignment plan and global shared services plan. This multi-year realignment focuses on globalizing the Company's service organization and creating a unified center-led global organization for research and development, as well as transforming the Company's general and administrative cost structure. Restructuring charges of $696 and $7,555 for the three months ended June 30, 2014 and 2013, respectively, and $5,833 and $17,058 for the six months ended June 30, 2014 and 2013, respectively, related to the Company's multi-year realignment plan. Restructuring charges for the six months ended June 30, 2014 primarily related to a business process outsourcing initiative. As of June 30, 2014, the Company anticipates additional restructuring costs of $7,500 to $10,000 to be incurred through the end of 2014, primarily within NA and EMEA. As management finalizes certain aspects of the realignment plan, the anticipated future costs related to this plan are subject to change. As of June 30, 2014, cumulative total restructuring costs for the multi-year realignment plan were $62,849, $2,866, $5,534, $1,694 and $8,635 in NA, AP, EMEA, LA and Brazil, respectively.








The following table summarizes the Company’s restructuring accrual balances and related activity:
 
 
2014
 
2013
Balance at January 1
 
$
35,289

 
$
11,844

Liabilities incurred
 
5,833

 
17,058

Liabilities paid/settled
 
(33,123
)
 
(17,788
)
Balance at June 30
 
$
7,999

 
$
11,114


Other Charges
Other charges consist of items that the Company has determined are non-routine in nature and are not expected to recur in future operations. Net non-routine income (expenses) of $11,074 and $(54,386) impacted the six months ended June 30, 2014 and 2013, respectively. Non-routine income for the first six months of 2014 related primarily to a $13,709 pre-tax gain from the sale of the Eras, recognized in gain on sale of assets, net in the condensed consolidated statements of operations. Non-routine expenses for the first six months of 2013 included $28,000 of additional pre-tax losses related to the settlement of the global Foreign Corrupt Practices Act investigation, a $17,500 pre-tax charge related to settlement of the securities legal action and executive severance costs, including accelerated share-based compensation expense of $2,982 (pre-tax) all recognized in selling and administrative expense, partially offset by non-routine income of $2,191 related to a pre-tax gain from the sale of certain U.S. manufacturing operations to a long-time supplier recognized in gain on sale of assets, net in the condensed consolidated statements of operations.